Rankinen Jani, Haataja Petri, Lyytikäinen Leo-Pekka, Huhtala Heini, Lehtimäki Terho, Kähönen Mika, Eskola Markku, Pérez-Riera Andrés Ricardo, Jula Antti, Niiranen Teemu, Nikus Kjell, Hernesniemi Jussi
Faculty of Medicine and Health Technology, Tampere University, and Finnish Cardiovascular Research Center, Tampere, Finland.
Heart Center, Department of Cardiology, Tampere University Hospital, Tampere, Finland.
Int J Cardiol Heart Vasc. 2020 Sep 25;31:100639. doi: 10.1016/j.ijcha.2020.100639. eCollection 2020 Dec.
Intraventricular conduction delays (IVCDs) are hallmarks of heart failure (HF) and structural heart disease (SHD) but their prognostic value for HF and SHD is unclear.
Relation of eight IVCDs and the incidence of first-time HF or SHD was studied in a nationally representative random sample of 6080 Finnish subjects aged ≥ 30 years (mean age 52.1, SD 14.5 years) who participated in the health examination including 12-lead ECG.
During 16.5 years' follow up, half of the subjects with left bundle branch block (LBBB) and one third of the subjects with non-specific IVCD developed HF. After controlling for known clinical risk factors the hazard ratio (HR) for new-onset HF for LBBB was 3.29 (95% confidence interval 1.93-5.63, P < 0.001) and 3.53 for non-specific IVCD (1.65-7.55, P = 0.001). In corresponding analysis, LBBB predicted SHD with HR 2.60 (1.21-5.62, P = 0.015). Excluding subjects with history of heart disease, including coronary heart disease, did not have impact on results. Right bundle branch block and other IVCDs displayed no relation to endpoints.
LBBB and non-specific IVCD were associated with more than three-fold risk of new-onset HF. Furthermore, LBBB was associated with novel SHD. Their presence should alert clinician even in subjects free from any known heart disease.
室内传导延迟(IVCDs)是心力衰竭(HF)和结构性心脏病(SHD)的特征,但它们对HF和SHD的预后价值尚不清楚。
在6080名年龄≥30岁(平均年龄52.1岁,标准差14.5岁)的芬兰受试者的全国代表性随机样本中,研究了8种IVCDs与首次发生HF或SHD的发生率之间的关系,这些受试者参加了包括12导联心电图在内的健康检查。
在16.5年的随访期间,左束支传导阻滞(LBBB)患者中有一半、非特异性IVCD患者中有三分之一发生了HF。在控制已知临床危险因素后,LBBB新发HF的风险比(HR)为3.29(95%置信区间1.93 - 5.63,P < 0.001),非特异性IVCD为3.53(1.65 - 7.55,P = 0.001)。在相应分析中,LBBB预测SHD的HR为2.60(1.21 - 5.62,P = 0.015)。排除有心脏病史(包括冠心病)的受试者对结果没有影响。右束支传导阻滞和其他IVCDs与终点事件无关联。
LBBB和非特异性IVCD与新发HF的风险增加三倍以上相关。此外,LBBB与新发SHD相关。即使在没有任何已知心脏病的受试者中,它们的存在也应提醒临床医生注意。